For the evaluation of the individual risk of distant metastasis, the established prognosis factors, size of the tumour, lymph node status, grading, PVI (peritumoral venous invasion) and the estrogen receptor and progesteron receptor status as well as the HER-2/new-overexpression were taken into account. Here, ERBB2 is linked to neoplasm.